DE60142634D1 - Erkennung von tumor-spezifischen genprodukten bei krebs - Google Patents

Erkennung von tumor-spezifischen genprodukten bei krebs

Info

Publication number
DE60142634D1
DE60142634D1 DE60142634T DE60142634T DE60142634D1 DE 60142634 D1 DE60142634 D1 DE 60142634D1 DE 60142634 T DE60142634 T DE 60142634T DE 60142634 T DE60142634 T DE 60142634T DE 60142634 D1 DE60142634 D1 DE 60142634D1
Authority
DE
Germany
Prior art keywords
tumor
specific gene
gene products
detection
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60142634T
Other languages
English (en)
Inventor
Dongen Jacobus Johannes Van
Der Velden Vincent Henricus Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Erasmus Universiteit Rotterdam
Original Assignee
Erasmus Universiteit Rotterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erasmus Universiteit Rotterdam filed Critical Erasmus Universiteit Rotterdam
Application granted granted Critical
Publication of DE60142634D1 publication Critical patent/DE60142634D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DE60142634T 2000-12-29 2001-12-28 Erkennung von tumor-spezifischen genprodukten bei krebs Expired - Lifetime DE60142634D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/752,635 US6686165B2 (en) 1997-05-20 2000-12-29 Recognition of tumor-specific gene products in cancer
PCT/NL2001/000945 WO2002054074A2 (en) 2000-12-29 2001-12-28 Recognition of tumor-specific gene products in cancer

Publications (1)

Publication Number Publication Date
DE60142634D1 true DE60142634D1 (de) 2010-09-02

Family

ID=25027138

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60142634T Expired - Lifetime DE60142634D1 (de) 2000-12-29 2001-12-28 Erkennung von tumor-spezifischen genprodukten bei krebs

Country Status (10)

Country Link
US (1) US6686165B2 (de)
EP (1) EP1348126B1 (de)
JP (1) JP2004523740A (de)
CN (1) CN1493000A (de)
AT (1) ATE475097T1 (de)
AU (1) AU2002226810B2 (de)
CA (1) CA2433556A1 (de)
DE (1) DE60142634D1 (de)
ES (1) ES2348706T3 (de)
WO (1) WO2002054074A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0878552A1 (de) * 1997-05-13 1998-11-18 Erasmus Universiteit Rotterdam Molekularer Nachweis von chromosomalen Veränderungen
JP2002513587A (ja) * 1998-05-04 2002-05-14 ダコ エー エス 染色体異常を検出するための方法およびプローブ
ATE480774T1 (de) * 2002-11-07 2010-09-15 Univ Erasmus Verfahren und proben zur detektion des tumor spezifische fusion proteinen
WO2004050870A2 (en) * 2002-12-05 2004-06-17 Ludwig-Maximilians-Uni Versität Genetic switches for the detection of fusion proteins
EP1507147A1 (de) * 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Verfahren zum Nachweiss von niedrigem Gehalt an Fusionsprotein
US20050214301A1 (en) * 2004-03-24 2005-09-29 Cell Signaling Technology, Inc. Antibodies specific for BCR-ABL fusion protein and uses thereof
WO2007061684A1 (en) * 2005-11-18 2007-05-31 Board Of Regents, The University Of Texas System Quantification of fusion proteins and their activity from chromosomal translocation
EP2108956A1 (de) 2008-04-07 2009-10-14 Erasmus University Medical Center Rotterdam Verbesserte Verfahren und Kits zum Erkennen von tumorspezifischen Fusionsproteinen
RU2558797C2 (ru) 2009-10-20 2015-08-10 Нестек С.А. Способы выявления онкогенных слитых белков, основанные на анализе близкого взаимного расположения
US9034658B2 (en) * 2009-11-23 2015-05-19 The General Hospital Corporation Microfluidic devices for the capture of biological sample components
US20120065092A1 (en) * 2010-09-14 2012-03-15 Wai Hobert Fusion analyte cytometric bead assay, and systems and kits for performing the same
KR101479543B1 (ko) 2013-03-15 2015-01-07 서강대학교산학협력단 Ｔｆｇ－ｔｅｃ 융합 컨스트럭트를 이용한 종양 질환의 예방 또는 치료용 물질의 스크리닝 방법 및 이의 용도
JP2018184369A (ja) * 2017-04-26 2018-11-22 株式会社明治 知的作業能力向上用組成物および認知能力向上用組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083709A (en) * 1985-08-21 2000-07-04 Osi Pharmaceuticals, Inc. Immunoassay for detection of mutant P53 polypeptide in serum
US4788138A (en) * 1987-04-30 1988-11-29 Beckman Instruments, Inc. Method to achieve a linear standard curve in a sandwich immunoassay
NO164622C (no) * 1988-05-11 1990-10-24 Tore Lindmo Binaer immunometrisk partikkelbasert metode for maaling av spesifikke serum-antigener ved hjelp av vaeskestroemsmikrofotometri og et ferdigpreparert maaloppsett derav.
AU628921B2 (en) * 1989-01-19 1992-09-24 Teijin Limited Immunoassay method, reagent and kit
AU6882791A (en) 1989-11-22 1991-06-13 Children's Hospital Of Los Angeles Bcr/abl transgenic animals as models for philadelphia chromosome positive chronic myelogenous and acute lymphoblastic leukemia
WO1992021032A1 (en) * 1991-05-24 1992-11-26 The Regents Of The University Of California Methods for the detection of bcr-abl and abnormal abl proteins in leukemia patients
FR2691475B1 (fr) * 1992-05-20 1995-03-24 Centre Nat Rech Scient Séquence d'ADN des produits de fusion résultant de la translocation chromosomique récurrente t(11;22) (q24;q12) associée au développement d'un groupe de tumeurs cancéreuses.
US5667981A (en) 1994-05-13 1997-09-16 Childrens Hospital Of Los Angeles Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein
DE4444969C1 (de) 1994-12-16 1996-10-24 Orga Med Dr Med Erwin Klopfer Nachweis von Antikörpern gegen p53 in Körperflüssigkeiten
US6159748A (en) * 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
PT983510E (pt) * 1997-05-20 2004-06-30 Univ Erasmus Reconhecimento de produtos geneticos especificos de tumor em cancro
US6150110A (en) * 1998-02-28 2000-11-21 The Brigham And Women's Hospital, Inc. HMGI(Y)-LAMA4* fusion oncogene, oncoprotein and methods of use

Also Published As

Publication number Publication date
ATE475097T1 (de) 2010-08-15
EP1348126B1 (de) 2010-07-21
EP1348126A2 (de) 2003-10-01
US20020042056A1 (en) 2002-04-11
JP2004523740A (ja) 2004-08-05
CA2433556A1 (en) 2002-07-11
WO2002054074A2 (en) 2002-07-11
CN1493000A (zh) 2004-04-28
WO2002054074A3 (en) 2003-01-23
AU2002226810B2 (en) 2007-05-10
ES2348706T3 (es) 2010-12-13
US6686165B2 (en) 2004-02-03

Similar Documents

Publication Publication Date Title
Armbrecht et al. Recent advances in the analysis of single cells
KR102243597B1 (ko) 세포로의 선택적 물질 전달
DE60142634D1 (de) Erkennung von tumor-spezifischen genprodukten bei krebs
AU2014204426B2 (en) Integrated nucleic acid analysis
Hilton et al. Advances in the analysis of single extracellular vesicles: A critical review
ATE445841T1 (de) Verfahren zur spezifischen detektion von tumorzellen und ihren vorstufen in gebärmutterhalsabstrichen durch simultane messung von mindestens 2 verschiedenen molekularen markern
Voronin et al. Detection of rare objects by flow cytometry: imaging, cell sorting, and deep learning approaches
FI20020355A (fi) Reagenssi ja prosessi biologisten solujen identifioimiseksi ja laskemiseksi
Plouffe et al. Perspective on microfluidic cell separation: A solved problem?
BR9916840A (pt) Sistema de detecção biológica portátil integrado
ATE544070T1 (de) Verfahren zum nachweis von tumorspezifischen fusionsproteinen
DK0983510T3 (da) Genkendelse af tumorspecifikke genprodukter i cancer
Oh et al. Rapid serial immunoprofiling of the tumor immune microenvironment by fine needle sampling
ATE507304T1 (de) Nachweis von chromosomalen anormalitäten in aus follikularer flüssigkeit erhaltenen zellen
BRPI0001536A (pt) método para diagnosticar a infecção por parasitos do genero schistosoma e kit para uso no diagnóstico da infecção por schistosoma sp
Zhao et al. Application of the Ludox-QPS method for estimating ciliate diversity in soil and comparison with direct count and DNA fingerprinting
Railean et al. Flow Cytometry–Sophisticated Tool for Basic Research or/and Routine Diagnosis; Impact of the Complementarity in Both Pre-as Well as Clinical Studies
Geethalakshmi et al. Utilization of flow cytometry in nanomaterial/bionanomaterial detection
Love Micro-and nanosystems for biotechnology
US20210010066A1 (en) Devices and methods for nucleic acid identification
Dogra et al. Sequencing and reproducibility analyses of small RNA extracted from prostate cancer exosomes isolated using nanoDLD chip technology
Tiirikainen Detection of intracellular antigens by flow cytometry: Evaluation of a new permeabilization method for the detection of intracellular antigens in hematological malignancies.